A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

Authors:

Kamel Chettab Chantel Fitzsimmons Alexey Novikov Morgane Denis Capucine Phelip Doriane Mathé Pierre Antoine Choffour Sabine Beaumel Eric Fourmaux Patrick Norca David Kryza Anne Evesque Lars Petter Jordheim Emeline Perrial Eva-Laure Matera Martine Caroff Jerome Kerzerho and Charles Dumontet